<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">epidemiology</journal-id><journal-title-group><journal-title xml:lang="ru">Эпидемиология и Вакцинопрофилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Epidemiology and Vaccinal Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2073-3046</issn><issn pub-type="epub">2619-0494</issn><publisher><publisher-name>«Numicom» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31631/2073-3046-2021-20-5-21-31</article-id><article-id custom-type="elpub" pub-id-type="custom">epidemiology-1359</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Анализ и перспективы развития эпидемической ситуации по кори в условиях пандемии COVID-19</article-title><trans-title-group xml:lang="en"><trans-title>Analysis and Outlook for the Development of Measles Epidemic Situation during the COVID-19 Pandemic</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6686-9011</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семененко</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Semenenko</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Татьяна Анатольевна Семененко – д. м. н., профессор, академик РАЕН, руководитель отдела эпидемиологии</p><p>123098, г. Москва, ул. Гамалеи, д. 18.</p><p>+7 (499) 190-72-56</p><p> </p></bio><bio xml:lang="en"><p>Tat’yana A. Semenenko – Dr. Sci. (Med.), professor, head of the Department of Epidemiology</p><p>18, Gamalei str., Moscow, 123098</p><p>+7 (499) 190-72-56</p></bio><email xlink:type="simple">semenenko@gamaleya.org</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8521-1741</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ноздрачева</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nozdracheva</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Анна Валерьевна Ноздрачева – к. м. н., научный сотрудник отдела эпидемиологии</p><p>123098, г. Москва, ул. Гамалеи, д. 18</p><p>+7 (499) 193-43-00</p></bio><bio xml:lang="en"><p>Аnna V. Nozdrachevа – Cand. Sci. (Med.), researcher the Department of Epidemiology</p><p>18, Gamalei str., Moscow, 123098</p><p>+7 (499) 193-43-00</p></bio><email xlink:type="simple">nozdracheva0506@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный исследовательский центр эпидемиологии и микробиологии имени Н. Ф. Гамалеи» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Research Centre of Epidemiology and Microbiology named after N.F. Gamaleya of the Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>03</day><month>11</month><year>2021</year></pub-date><volume>20</volume><issue>5</issue><fpage>21</fpage><lpage>31</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Семененко Т.А., Ноздрачева А.В., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Семененко Т.А., Ноздрачева А.В.</copyright-holder><copyright-holder xml:lang="en">Semenenko T.A., Nozdracheva A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.epidemvac.ru/jour/article/view/1359">https://www.epidemvac.ru/jour/article/view/1359</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Успехи мирового сообщества в борьбе с корью с помощью вакцинации в начале XXI века позволили ВОЗ поставить цель – элиминировать инфекцию к 2010 г. Однако десять лет спустя от намеченного срока проблема роста заболеваемости корью стала вновь актуальной для всех стран мира. Пандемия новой коронавирусной инфекции (COVID-19) отразилась на всех сферах жизни человека и обострила ситуацию по борьбе с другими инфекциями, в том числе управляемыми средствами специфической профилактики. Так как индекс контагиозности кори и смертность от нее значительно выше, чем аналогичные характеристики COVID-19, опасность роста заболеваемости этой инфекцией в ближайшие годы трудно переоценить.</p></sec><sec><title>Цель исследования</title><p>Цель исследования: оценить эпидемическую ситуацию по кори в условиях пандемии COVID-19, а также перспективы ее развития; предложить меры профилактики.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В статье проанализированы статистические материалы, доступные на официальных сайтах ВОЗ (https://www.who.int/data/), Центра по контролю заболеваний США (https://www.cdc.gov) и Роспотребнадзора (https://www.rospotrebnadzor.ru/) об охвате вакцинацией и заболеваемости корью в 13 странах Европейского региона ВОЗ и США. Эпидемическая ситуация по кори, а также уровень охвата населения вакцинацией против ее возбудителя в РФ оценены по данным форм статистической отчетности 2010–2020 гг.</p></sec><sec><title>Результаты</title><p>Результаты. Установлено, что рост заболеваемости корью имел место в 2017–2019 гг. во всем мире, в том числе в европейских странах с охватом населения двумя прививками на уровне 97% в 2010–2019 гг. Показано преобладание в структуре заболевших корью детей в возрасте до 10 лет, а также варьирование в широких пределах (от 56,9% до 10,9%) доли привитых среди них. Полученные результаты свидетельствуют о существовании проблем в организации вакцинопрофилактики. Введение повсеместных ограничительных и карантинных мероприятий на фоне пандемии COVID-19, с одной стороны, позволили снизить заболеваемость корью, а с другой стороны, усугубили трудности в проведении профилактической работы в отношении кори. Таким образом, результаты работы свидетельствуют о возможном росте заболеваемости корью среди населения после завершения пандемии COVID-19.</p></sec><sec><title>Заключение</title><p>Заключение. Необходима незамедлительная разработка плана мероприятий по наверстыванию объемов и темпов плановой вакцинации, совершенствованию статистического учета лиц, подлежащих иммунизации и привитых, а также по преодолению антивакцинальных настроений среди населения.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Relevance</title><p>Relevance. The success of the global community in the fight against measles through vaccination at the beginning of the twentyfirst century allowed WHO to declare the goal of eliminating this infection by 2010. However, ten years later, the problem of the growing incidence of measles has become relevant again for all countries of the world. The pandemic of the new coronavirus infection (COVID-19) has affected all spheres of human life and has exacerbated the situation in the fight against other infections, including those managed with the help of specific prophylaxis. Since the measles contagiosity index and mortality rate are significantly higher than similar characteristics of COVID-19, the risk of increasing the incidence of this infection in the coming years is difficult to overestimate.</p></sec><sec><title>Aim of the study</title><p>Aim of the study: to assess the epidemic situation of measles in the context of the COVID-19 pandemic, as well as the prospects for its development; to propose preventive measures.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The article analyzes the statistical materials available on the official websites of the WHO (WHO). https://www.who.int/data/), the CDC US (https://www. cdc.gov) and the Federal Service of Rospotrebnadzor (https://www.rospotrebnadzor.ru/) on vaccination coverage and measles incidence in 13 countries in the WHO European Region and the United States. The epidemic situation on measles, as well as the level of population coverage with vaccination against its pathogen in the Russian Federation, were assessed according to the Federal State Statistical Observation forms 2010 – 2020: Form 2 «Information on infectious and parasitic diseases» and Form 6 «Information on the populations of children and adults vaccinated against infectious diseases».</p></sec><sec><title>Results</title><p>Results. It has been established that the increase in the measles incidence occurred in 2017–2019 worldwide, including European countries with a population coverage of two vaccine doses at the 97% level between 2010 and 2019. The prevalence of measles cases in children under the age of 10 is shown, as well as the wide range (from 56.9% to 10.9%) in the proportion of vaccinated persons among them. The results obtained indicate the existence of problems in the organization of modern vaccine prevention. The introduction of widespread restrictive and quarantine measures against the COVID-19 pandemic, on the one hand, has reduced the incidence of measles and, on the other hand, has exacerbated the difficulties in implementing measles prevention. Thus, the results indicate a possible increase in measles incidence in the population after the end of the COVID-19 pandemic.</p></sec><sec><title>Conclusion</title><p>Conclusion. It is necessary to immediately develop an action plan to catch up on the coverage and increase the rate of routine vaccination, to improve the statistical record of persons subject to the introduction of the vaccine and vaccinated, as well as to overcome anti-vaccination attitude among the population.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>корь</kwd><kwd>вакцинопрофилактика</kwd><kwd>последствия пандемии COVID-19</kwd><kwd>охват вакцинацией</kwd></kwd-group><kwd-group xml:lang="en"><kwd>measles</kwd><kwd>vaccine prevention</kwd><kwd>consequences of the COVID-19 pandemic</kwd><kwd>vaccination coverage No conflict of interest to declare</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Руководство по эпидемиологическому надзору за корью, краснухой и синдромом врожденной краснухи в Европейском регионе ВОЗ. Copenhagen: WHO, Обновленное издание. 2012. Доступно на: http://www.euro.who.int/__data/assets/pdf_file/0017/126422/e93035R-final.pdf. Ссылка активна на 26 мая 2021.</mixed-citation><mixed-citation xml:lang="en">Surveillance Guidelines for Measles, Rubella and Congenital Rubella Syndrome in the WHO European Region. – Copenhagen: WHO, Update December. 2012. Available at: http://www.euro.who.int/__ data/assets/pdf_file/0017/126422/e93035R-final.pdf. Accessed: 26 May 2021.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Nicolay N, Mirinaviciute G, Mollet T, et al. Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom, January to May 2020. Euro Surveill. 2020; 25(31): pii=2001390. https://doi:10.2807/1560-7917.ES.2020.25.31.2001390</mixed-citation><mixed-citation xml:lang="en">Nicolay N, Mirinaviciute G, Mollet T, et al. Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom, January to May 2020. Euro Surveill. 2020; 25(31):2001390. https://doi: 10.2807/1560-7917.ES.2020.25.31.2001390</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Центр СМИ: Выпуски новостей за 2009 год. Глобальная смертность от кори снизилась на 78%, но она может снова возрасти. Доступно на: https://www.who.int/mediacentre/news/ releases/2009/measles_mdg_20091203/ru/ Ссылка активна на 26 мая 2021.</mixed-citation><mixed-citation xml:lang="en">Media Center 2009 News Releases Global measles deaths drop 78%, but may rise again. Available at: https://www.who.int/mediacentre/news/releases/2009/measles_mdg_20091203/ru/. Accessed: 26 May 2021.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Центр СМИ: Вспышки кори продолжают распространяться по Европе: ВОЗ призывает к вакцинации. Доступно на: https://www.euro.who.int/ru/health-topics/disease-prevention/vaccinesand-immunization/news/news/2011/03/measles-outbreaks-continue-across-europe-who-says,-get-vaccinated. Ссылка активна на 26 мая 2021.</mixed-citation><mixed-citation xml:lang="en">Media Center: Measles outbreaks continue across Europe: WHO says, get vaccinated. Available at: https://www.euro.who.int/ru/health-topics/disease-prevention/vaccines-and-immunization/news/ news/2011/03/measles-outbreaks-continue-across-europe-who-says,-get-vaccinated/. Accessed: 26 May 2021.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Семененко Т. А., Ежлова Е. Б., Ноздрачева А. В. и др. Особенности проявлений эпидемического процесса кори в Москве в 1992 - 2014 годах. Эпидемиология и Вакцинопрофилактика. 2015; 14(6):16-22. https://doi:10.31631/2073-3046-2015-14-6-16-22.</mixed-citation><mixed-citation xml:lang="en">Semenenko T.A., Ezhlova E.B., Nozdracheva A.V., et al. Manifestation Features of the Measles Epidemic Process in Moscow in 1992 - 2014.  Epidemiology and Vaccinal Prevention. 2015;14(6):16-22 (In Russ). https://doi: 10.31631/2073-3046-2015-14-6-16-22</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Thornton J. Measles cases in Europe tripled from 2017 to 2018. BMJ. 2019; 364:l-634-l-634.</mixed-citation><mixed-citation xml:lang="en">Thornton J. Measles cases in Europe tripled from 2017 to 2018. BMJ. 2019;364:l-634-l-634.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Patel MK, Goodson JL, Alexander JP, et al. Progress Toward Regional Measles Elimination – Worldwide, 2000–2019. MMWR Morb Mortal Wkly Rep. 2020;.69(45):1700-1705. https://doi: 10.15585/mmwr. mm6945a6.</mixed-citation><mixed-citation xml:lang="en">Patel MK, Goodson JL, Alexander JP Jr, et al. Progress Toward Regional Measles Elimination – Worldwide, 2000-2019. MMWR Morb Mortal Wkly Rep. 2020; 69(45):1700=1705. https://doi: 10.15585/ mmwr.mm6945a6.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Акимкин В. Г., Кузин С. Н., Семененко Т. А. и др. Закономерности эпидемического распространения SARS-CoV-2 в условиях мегаполиса. Вопросы вирусологии. 2020; 65(4):203-211. https:// doi:10.36233/0507-4088-2020-65-4-203-211.</mixed-citation><mixed-citation xml:lang="en">Akimkin V.G., Kuzin S.N., Semenenko T.A., et al. Patterns of the SARS-CoV-2 epidemic spread in a megacity. Problems of Virology. 2020; 65(4):203-211. (In Russ). https://doi:10.36233/0507-4088-2020- 65-4-203-211.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Roberton T, Carter ED, Chou VB, et al. Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: A modelling study. Lancet Glob. Health. 2020; 8:901-908. https://doi: 10.1016/S2214-109X(20)30229-1.</mixed-citation><mixed-citation xml:lang="en">Roberton T, Carter ED, Chou VB, et al. Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: A modelling study. Lancet Glob. Health. 2020; 8:901–908. https://doi: 10.1016/S2214-109X(20)30229-1.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization: At Least 80 Million Children under One at Risk of Diseases Such As Diphtheria, Measles and Polio as COVID-19 Disrupts Routine Vaccination Efforts. Warn Gavi, WHO and UNICEF. Доступно на: https://www.who.int/news/item/22-05-2020-at-least-80-million-children-under-one-at-risk-of-diseases-such-as-diphtheria-measles-and-polio-as-covid-19-disrupts-routinevaccination-efforts-warn-gavi-who-and-unicef. Ссылка активна на 26 мая 2021.</mixed-citation><mixed-citation xml:lang="en">World Health Organization: At Least 80 Million Children under One at Risk of Diseases Such As Diphtheria, Measles and Polio as COVID-19 Disrupts Routine Vaccination Efforts, Warn Gavi, WHO and UNICEF. Available at:  https://www.who.int/news/item/22-05-2020-at-least-80-million-children-under-one-at-risk-of-diseases-such-as-diphtheria-measles-and-polio-as-covid-19-disrupts-routinevaccination-efforts-warn-gavi-who-and-unicef. Accessed: 26 May 2021.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Dinleyici EC, Borrow R, Safadi MAP, et al. Vaccines and routine immunization strategies during the COVID-19 pandemic. Hum. Vaccin. Immunother. 2020; 17(6):1858-1866. https://doi:10.1080/216455 15.2020.1804776.</mixed-citation><mixed-citation xml:lang="en">Dinleyici EC, Borrow R, Safadi MAP, et al. Vaccines and routine immunization strategies during the COVID-19 pandemic. Hum. Vaccin. Immunother. 2020:1-8. https://doi: 10.1080/21645515.2020.1804 776.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">UNICEF Immunization Coverage: Are We Losing Ground? Доступно на: https://data.unicef.org/resources/immunization-coverage-are-we-losing-ground/. Ссылка активна на 26 мая 2021.</mixed-citation><mixed-citation xml:lang="en">UNICEF Immunization Coverage: Are We Losing Ground? Available at: https://data.unicef.org/resources/immunization-coverage-are-we-losing-ground/. Accessed: 26 May 2021.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Руководство по плановой иммунизации во время пандемии COVID-19 в Европейском регионе ВОЗ. ВОЗ. Европейское региональное бюро. 20.03.2020г. Доступно на: https://apps.who.int/iris/ bitstream/handle/10665/334124/WHO-EURO-2020-1059-40805-55115-rus.pdf. Ссылка активна на 26 мая 2021.</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Regional Office for Europe . (2020). Guidance on routine immunization services during COVID-19 pandemic in the WHO European Region, 20 March 2020// World Health Organization. Regional Office for Europe. Available at: https://apps.who.int/iris/bitstream/handle/10665/334124/WHO-EURO-2020-1059-40805-55115-rus.pdf. Accessed: 26 May 2021.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Stefanati A, d’Anchera E, De Motoli F, et al. Value of Immunizations during the COVID-19 Emergency. Int J Environ Res Public Health. 2021; 18(2):778. https://doi: 10.3390/ijerph18020778.</mixed-citation><mixed-citation xml:lang="en">Stefanati A, d’Anchera E, De Motoli F, at al. Value of Immunizations during the COVID-19 Emergency. Int J Environ Res Public Health. 2021; 18(2):778. https://doi: 10.3390/ijerph18020778.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ноздрачева А. В., Семененко Т. А. Состояние популяционного иммунитета к кори в России: систематический обзор и метаанализ эпидемиологических исследований. Журнал микробиологии, эпидемиологии и иммунобиологии. 2020;97(5):445-457. https://doi: https://doi.org/10.36233/0372-9311-2020-97-5-7.</mixed-citation><mixed-citation xml:lang="en">Nozdracheva AV, Semenenko TA. The status of herd immunity to measles in Russia: A systematic review and meta-analysis of epidemiological studies. Journal of microbiology, epidemiology and immunobiology. 2020; 97(5): 445=457. (In Russ). https://doi: 10.36233/0372-9311-2020-97-5-7.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ноздрачева А. В., Семененко Т. А., Асатрян М. Н. и др. Иммунологическая восприимчивость населения мегаполиса к кори на этапе ее элиминации. Эпидемиология и Вакцинопрофилактика. 2019;18(2):18-26. https://doi:10.31631/2073-3046-2019-18-2-18-26.</mixed-citation><mixed-citation xml:lang="en">Nozdracheva A.V., Asatryan M.N., Asatryan M.N., et al. Immunological Susceptibility of Metropolis Population to Measles in its Elimination Stage. Epidemiology and Vaccinal Prevention. 2019;18(2):18-26 (In Russ).  https://doi: 10.31631/2073-3046-2019-18-2-18-26.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Guerra F, Bolotin S, Lim G, et al. The basic reproduction number (Ro) of measles: a systematic review. Lancet Infect. Dis. 2017;17(12):420-428.</mixed-citation><mixed-citation xml:lang="en">Guerra F, Bolotin S, Lim G, et al. The basic reproduction number (Ro) of measles: a systematic review. Lancet Infect. Dis. 2017; 17(12): 420-428.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Warn of a decline in vaccinations during COVID-19.15 July 2020. News release// WHO and UNICEF. Geneva/New York. Доступно на: https://www.who.int/news/item/15-07-2020-who-and-unicefwarn-of-a-decline-in-vaccinations-during-covid-19. Ссылка активна на 26 мая 2021.</mixed-citation><mixed-citation xml:lang="en">Warn of a decline in vaccinations during COVID-19. WHO and UNICEF. 15 July 2020. News release. Geneva/New York. Available at: https://www.who.int/news/item/15-07-2020-who-and-unicef-warnof-a-decline-in-vaccinations-during-covid-19. Accessed: 26 May 2021.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Paules CI, Marston HD, Fauci AS. Measles in 2019 – Going Backward. N Engl J Med. 2019;380(23):2185-2187. https://doi: 10.1056/NEJMp1905099</mixed-citation><mixed-citation xml:lang="en">Paules CI, Marston HD, Fauci AS. Measles in 2019 - Going Backward. N Engl J Med. 2019 Jun 6; 380(23):2185-2187. https://doi: 10.1056/NEJMp1905099.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Корь – Европейский Регион. Эпидемиология и Вакцинопрофилактика. 2019; 18(3):12.</mixed-citation><mixed-citation xml:lang="en">Measles-European Region. Epidemiology and Vaccinal Prevention. 2019; 18(3):12.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Семененко Т. А., Сметанина С. В., Колобухина Л. В., Кареткина Г. Н., Ноздрачева А. В. и др. Корь: эпидемиологические особенности в период элиминации, современные возможности профилактики, диагностики и лечения. Значение серологического исследования популяционного иммунитета населения. Департамент здравоохранения города Москвы. Методические рекомендации №74. 2020: 38 с.</mixed-citation><mixed-citation xml:lang="en">Semenenko T.A., Smetanina S.V., Kolobuhina L.V., et al. Measles: epidemiological features during the elimination period, modern possibilities of prevention, diagnostics and treatment. The importance of serological study of herd immunity. Guidelines №74. 2020: 38 p. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Фельдблюм И. B., Романенко В. В., Субботина К. А. и др. Безопасность и иммунологическая эффективность отечественной комбинированной тривакцины для профилактики кори, краснухи и эпидемического паротита Вактривир® при иммунизации детей 12 месяцев и 6 лет (результаты простого слепого мультицентрового сравнительного рандомизированного клинического исследования). Эпидемиология и Вакцинопрофилактика. 2021; 20(1):32-43. https://doi:10.31631/2073-3046-2021-20-1-32-43</mixed-citation><mixed-citation xml:lang="en">Feldblium I.V., Romanenko V.V., Subbotina K.A., et al. Safety and immunological effectiveness of the domestic combined trivaccine for the prevention of measles, rubella and mumps Vaktrivir® in children 12 months and 6 years of age (results of a simple blind multicenter comparative randomized clinical trial). Epidemiology and Vaccinal Prevention. 2021; 20(1):32-43 (In Russ). https://doi: 10.31631/2073- 3046-2021-20-1-32-43.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Брико Н. И., Каграманян И. Н., Никифоров В. В. и др. Пандемия COVID-19. Меры борьбы с ее распространением в Российской Федерации. Эпидемиология и Вакцинопрофилактика. 2020; 19(2):4-12. https://doi:10.31631/2073-3046-2020-19-2-4-12.</mixed-citation><mixed-citation xml:lang="en">Briko N.I., Kagramanyan I.N., Nikiforov V.V., et al. COVID-19. Prevention Measures in the Russian Federation. Epidemiology and Vaccinal Prevention. 2020; 19(2):4-12 (In Russ). https://doi:10.31631/2073- 3046-2020-19-2-4-12.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Saxena S, Skirrow H, Bedford H. Routine vaccination during covid-19 pandemic response. BMJ. 2020;369: m2392. https://doi: 10.1136/bmj.m2392</mixed-citation><mixed-citation xml:lang="en">Saxena S, Skirrow H, Bedford H. Routine vaccination during covid-19 pandemic response. BMJ. 2020;369: m2392. https://doi: 10.1136/bmj.m2392</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Цвиркун О. В., Тихонова Н. Т., Тураева Н. В., Ежлова Е. Б., Мельникова А. А., Герасимова А. Г. Характеристика популяционного иммунитета к кори в Российской Федерации. Эпидемиология и Вакцинопрофилактика. 2020; 19(4): 6-13. https://doi:10.31631/2073-3046-2020-19-4-6-13</mixed-citation><mixed-citation xml:lang="en">Tsvirkun O.V., Tikhonova N.T., Turaeva N.T., Ezhlova E.B., Melnikova A.A., Gerasimova A.G. Population Immunity and Structure of Measles Cases in the Russian Federation. Epidemiology and Vaccinal Prevention. 2020;19(4):6-13. (In Russ.) https://doi:10.31631/2073-3046-2020-19-4-6-13.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Галина Н. П., Миндлина А. Я., Полибин Р. В. Анализ организации прививок детского и взрослого населения РФ против дифтерии, столбняка, кори и вирусного гепатита В. Инфекция и иммунитет. 2019; 9(5):779-786. https://doi: 10.15789/2220-7619-2019-5-6-779-786/.</mixed-citation><mixed-citation xml:lang="en">Galina N.P., Mindlina A.Y., Polibin R.V. Surveying children and adult vaccination program against diphtheria, tetanus, measles and viral hepatitis B in the Russian Federation. Russian Journal of Infection and Immunity. 2019;9(5-6):779-786 (In Russ).  https://doi:10.15789/2220-7619-2019-5-6-779-786</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Seither R, McGill MT, Kriss JL, et al. Vaccination Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten – United States, 2019-20 School Year. MMWR Morb Mortal Wkly Rep. 2021; 70(3):75-82. https://doi:10.15585/mmwr.mm7003a2</mixed-citation><mixed-citation xml:lang="en">Seither R, McGill MT, Kriss JL, Mellerson JL, Loretan C, Driver K, Knighton CL, Black CL. Vaccination Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten – United States, 2019-20 School Year. MMWR Morb Mortal Wkly Rep. 2021; 70(3):75-82. https://doi:10.15585/mmwr.mm7003a2.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Семененко Т.А., Ноздрачева А.В., Асатрян М.Н. и др. Комплексный анализ влияния вакцинации на формирование популяционного иммунитета к кори среди населения мегаполиса. Вестник РАМН. 2019; 74(5):351–360. https://doi:10.15690/vramn1170.</mixed-citation><mixed-citation xml:lang="en">Semenenko TA, Nozdracheva AV, Asatryan MN, et al. Multivariate analysis of the megacity population immunity to measles. Annals of the Russian Academy of  Medical Sciences. 2019; 74(5):351-360 (In Russ). https://doi: 10.15690/vramn1170.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Цвиркун О. В., Тихонова Н. Т., Ющенко Г. В., Герасимова А. Г. Эпидемический процесс кори в разные периоды ее вакцинопрофилактики. Эпидемиология и Вакцинопрофилактика. 2015; 14(2):80-87. https://doi:10.31631/2073-3046-2015-14-2-80-87.</mixed-citation><mixed-citation xml:lang="en">Tsvirkun O.V., Tihonova N.T., Yushchenko G.V., Gerasimova A.G. Measles Epidemic Process in Various Vaccinal Periods.  Epidemiology and Vaccinal Prevention. 2015;14(2):80-87 (In Russ.).  https:// doi:10.31631/2073-3046-2015-14-2-80-87.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Сайт о вакцинах и вакцинации. Доступно на: https://www.privivka.ru/ Ссылка активна на 26 мая 2021.</mixed-citation><mixed-citation xml:lang="en">Web site about vaccines and vaccinations. Available at: https://www.privivka.ru/. Accessed: 26 May 2021.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Measles &amp; Rubella Initiative. UNICEF and WHO call for emergency action to avert major measles and polio epidemics. Nov 6, 2020. Доступно на: https://measlesrubellainitiative.org/measles-news/ unicef-who-callemergency-action-avert-major-measles-polio-epidemics/ Ссылка активна на 26 мая 2021.</mixed-citation><mixed-citation xml:lang="en">Measles &amp; Rubella Initiative. UNICEF and WHO call for emergency action to avert major measles and polio epidemics. Nov 6, 2020. Available at: https://measlesrubellainitiative.org/ measles-news/unicef-who-callemergency-action-avert-major-measles-polio-epidemics/. Accessed: 26 May 2021.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Measles &amp; Rubella Initiative. Measles and Rubella Strategic Framework 2021–2030. 2020. Доступно на: https://s3.amazonaws.com/wp-agility2/measles/wpcontent/uploads/2020/11/measles-rubella-initiative-v10-singlepage.pdf. Ссылка активна на 26 мая 2021.</mixed-citation><mixed-citation xml:lang="en">Measles &amp; Rubella Initiative. Measles and Rubella Strategic Framework 2021–2030. 2020. Available at: https://s3.amazonaws.com/wp-agility2/measles/wpcontent/uploads/2020/11/ measles-rubella-initiative-v10-singlepage.pdf. Accessed: 26 May 2021.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">ЕНИ: Основные идеи и тезисы. Доступно на: https://www.euro.who.int/ru/media-centre/events/events/2021/04/european-immunization-week-2021/key-messages. Ссылка активна на 26 мая 2021.</mixed-citation><mixed-citation xml:lang="en">EIW: Key massages. Available at: https://www.euro.who.int/ru/media-centre/events/events/2021/04/european-immunization-week-2021/key-messages. Accessed: 26 May 2021. Accessed: 26 May 2021.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Центр по контролю заболеваемости США (CDC USA). Доступно на: https://www.cdc.gov. Ссылка активна на 26 мая 2021.</mixed-citation><mixed-citation xml:lang="en">CDC: Available at: https://www.cdc.gov. Accessed: 26 May 2021.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
